Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune System Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Not applicableStudy completedNCT01394276
What this trial is testing

An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 322
Testing effectiveness (Phase 2)Ended earlyNCT00082017
What this trial is testing

UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas

Who this might be right for
Lymphoma, Large-Cell, Ki-1Lymphoma, T-Cell
National Cancer Institute (NCI) 20
Not applicableActive Not RecruitingNCT03992417
What this trial is testing

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Who this might be right for
Dermatitis Atopic
Sanofi 955
Testing effectiveness (Phase 2)Study completedNCT00001789
What this trial is testing

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Who this might be right for
Glomerulonephritis, MembranoproliferativeLupus Nephritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Testing effectiveness (Phase 2)Study completedNCT03262389
What this trial is testing

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Michael C Roarke, MD 10
Testing effectiveness (Phase 2)Study completedNCT03823391
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 48
Large-scale testing (Phase 3)Ended earlyNCT01731691
What this trial is testing

Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease

Who this might be right for
HIV Disease
Institute for Human Genetics and Biochemistry 12
Testing effectiveness (Phase 2)Study completedNCT03651518
What this trial is testing

Personalized Therapies in Inflammatory Complex Disease

Who this might be right for
Inflammatory DiseaseAutoimmune Diseases
Assistance Publique - Hôpitaux de Paris 32
Not applicableUnknownNCT02488590
What this trial is testing

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAsthmaOverlap Syndrome
KU Leuven 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591597
What this trial is testing

A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer

Who this might be right for
Metastatic Colorectal NeoplasmsMicrosatellite Stable / Proficient Mismatch Repair Colorectal Cancer
National Cancer Center Hospital East 68
Testing effectiveness (Phase 2)UnknownNCT03902197
What this trial is testing

CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Xuanwu Hospital, Beijing 50
Large-scale testing (Phase 3)Study completedNCT00910910
What this trial is testing

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Celgene 450
Testing effectiveness (Phase 2)Study completedNCT05198310
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Who this might be right for
Arthritis, Rheumatoid
Kiniksa Pharmaceuticals, Ltd. 145
Testing effectiveness (Phase 2)Study completedNCT00802113
What this trial is testing

Autologous and Allogeneic Transplant for Relapsed Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaHodgkins Disease
Columbia University 30
Very early researchLooking for participantsNCT06787560
What this trial is testing

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

Who this might be right for
Bone Marrow Failure Syndrome
Zhejiang University 20
Not applicableLooking for participantsNCT05390424
What this trial is testing

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

Who this might be right for
Hepatitis BHepatitis CAIDS
University Hospital, Rouen 500
Not applicableStudy completedNCT03937323
What this trial is testing

Immun Status at Pancreatitis Patients

Who this might be right for
PancreatitisImmune Suppression
Istanbul Training and Research Hospital 80
Post-approval studies (Phase 4)Study completedNCT03098823
What this trial is testing

A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE

Who this might be right for
Lupus Erythematosus, SystemicLupus ErythematosusFatigue
Ampel BioSolutions, LLC 62
Not applicableStudy completedNCT03559959
What this trial is testing

A Field Experiment to Assess the Demand for HIV Self-Tests in Zimbabwe

Who this might be right for
HIV/AIDS
University of Pennsylvania 4,000
Next Page